Do You Still Need a COVID Vaccine in 2026?

Do You Still Need a COVID Vaccine in 2026?

The short answer = for most people .. no. 

But. For older and more vulnerable people .. yes.

As we move through the spring of 2026, the global approach to COVID-19 has transitioned from an “emergency” response to a seasonal health strategy.

For many, the question of whether to get another vaccine is no longer about mandates, but about personal health management and risk assessment.

With the emergence of the BA.3.2 “Cicada” variant, here is the latest medical consensus on who needs a vaccine this year and why.

1. The 2026 “Spring Booster” Campaign

As of April 2026, health organisations like the CDC and the NHS have launched the “Spring Booster” drive. Unlike the early days of the pandemic, these vaccines are now primarily targeted at populations where protection “wanes” the fastest or where the stakes of infection are highest.

Who is eligible for the 2026 Spring Booster?

• Adults aged 75 and over: Immunity in this age group tends to decline more rapidly.

• Care Home Residents: Due to the risk of congregate spread.

• Immunocompromised Individuals: Anyone aged 6 months and older with a weakened immune system (e.g. those undergoing chemotherapy or with certain chronic conditions like CKD).

2. Why Get Vaccinated Now? The “Cicada” Factor

The dominant strain in 2026, BA.3.2 (Cicada), is genetically distinct from the variants we saw in 2024. It carries approximately 70 mutations in its spike protein, which is the primary target for our immune systems.

The Reality Check

• Immune Evasion: The Cicada variant is highly effective at slipping past “old” antibodies from 2023 or 2024 infections.

  • • Waning Protection: Evidence shows that vaccine effectiveness against infection drops significantly after 6 months, though protection against severe hospitalisation remains more durable.

• Updated Antigens: The 2025–2026 vaccine formulas (such as the latest versions of Spikevax and Comirnaty) were specifically updated to target more recent lineages like LP.8.1, providing a much stronger “match” for the variants circulating right now.

3. What About Everyone Else?

If you are a healthy adult under 75 and not immunocompromised, the 2026 guidance shifts toward “individual-based decision making.”

You might still choose to get the 2026 vaccine if:

1. You Live with High-Risk People: To reduce the likelihood of bringing the virus into the home.

2. You Haven’t Had COVID Recently: If it has been more than a year since your last infection or dose, your antibody levels are likely at their baseline.

3. You Want to Avoid “Long COVID”: While vaccines don’t eliminate the risk, 2026 data continues to show that staying up-to-date with boosters reduces the probability of developing lingering symptoms.

4. Is the 2026 Vaccine Safe?

With over five years of global data and billions of doses administered, the safety profile of the mRNA and protein-based (Novavax) vaccines is well-documented. Common side effects in 2026 remain the same: a sore arm, fatigue, or a low-grade fever for 24–48 hours.

For the majority of people, the risk of “Post-Viral Syndrome” or heart complications from a natural COVID infection remains significantly higher than the rare risks associated with the vaccine.

2026 Vaccination Summary Table

The Bottom Line: In 2026, the COVID vaccine has become much like the annual flu shot—a tool to keep the most vulnerable out of the hospital and a way for the rest of us to minimise the disruption of a “bad week” of illness.

Are you or a family member currently eligible for the Spring Booster, or are you waiting for the combined COVID/Flu shot expected this autumn?